ATX Quarterly Activities/Appendix 4C Cash Flow Report 08:45 PRICE SENSITIVE download Created with Sketch. 283.77KB Share ATX Capital Raising Presentation 23/07/25 PRICE SENSITIVE download Created with Sketch. 3.15MB Share ATX Amplia announces A$25m Placement and Launches A$2.5m SPP 23/07/25 PRICE SENSITIVE download Created with Sketch. 238.25KB Share ATX Trading Halt 21/07/25 PRICE SENSITIVE download Created with Sketch. 170.35KB Share ATX Second Complete Response in ACCENT Pancreatic Cancer Trial 19/06/25 PRICE SENSITIVE download Created with Sketch. 168.47KB Share ATX Pathological Complete Response in Pancreatic Cancer Trial 16/06/25 PRICE SENSITIVE download Created with Sketch. 171.4KB Share ATX Preliminary Final Report and Annual Report YE 31 March 2025 30/05/25 PRICE SENSITIVE download Created with Sketch. 19.2MB Share ATX ACCENT Trial Achieves Superiority over Chemotherapy Alone 15/05/25 PRICE SENSITIVE download Created with Sketch. 180.82KB Share ATX Quarterly Activities/Appendix 4C Cash Flow Report 30/04/25 PRICE SENSITIVE download Created with Sketch. 308.18KB Share ATX Completion of Recruitment of ACCENT Trial 31/01/25 PRICE SENSITIVE download Created with Sketch. 175.06KB Share ATX Quarterly Activities/Appendix 4C Cash Flow Report 30/01/25 PRICE SENSITIVE download Created with Sketch. 280.81KB Share ATX Security Class Reinstatement to Quotation - ATXOA 23/12/24 PRICE SENSITIVE download Created with Sketch. 420.57KB Share ATX App 4D and Financial Report Half Year ended 30 Sep 2024 27/11/24 PRICE SENSITIVE download Created with Sketch. 874.67KB Share ATX Security Class Suspension from Quotation 25/11/24 PRICE SENSITIVE download Created with Sketch. 428.72KB Share ATX Amplia Successfully Completes Institutional Offer 01/11/24 PRICE SENSITIVE download Created with Sketch. 200.59KB Share ATX Capital Raise Presentation 30/10/24 PRICE SENSITIVE download Created with Sketch. 2.67MB Share ATX Amplia to Raise up to $13m for ACCENT and US Trials 30/10/24 PRICE SENSITIVE download Created with Sketch. 303.61KB Share ATX Interim Data From Accent Pancreatic Cancer Trial 30/10/24 PRICE SENSITIVE download Created with Sketch. 869.52KB Share ATX Quarterly Activities/Appendix 4C Cash Flow Report 30/10/24 PRICE SENSITIVE download Created with Sketch. 305.47KB Share ATX Trading Halt 30/10/24 PRICE SENSITIVE download Created with Sketch. 543.96KB Share ATX Sixth Confirmed Response in Pancreatic Cancer Trial 23/09/24 PRICE SENSITIVE download Created with Sketch. 171.78KB Share ATX FDA Fast Track Designation for Narmafotinib 20/09/24 PRICE SENSITIVE download Created with Sketch. 162.21KB Share ATX Fifth Confirmed Response in ACCENT Trial 21/08/24 PRICE SENSITIVE download Created with Sketch. 172.94KB Share ATX Amplia Receives R&D Tax Rebate Totalling $3.2 Million 12/08/24 PRICE SENSITIVE download Created with Sketch. 109.82KB Share ATX Granting of Key Patent in Europe and Japan 07/08/24 PRICE SENSITIVE download Created with Sketch. 162.82KB Share ATX Additional Patient Response in Pancreatic Cancer Trial 06/08/24 PRICE SENSITIVE download Created with Sketch. 171.48KB Share ATX Quarterly Activities/Appendix 4C Cash Flow Report 31/07/24 PRICE SENSITIVE download Created with Sketch. 311.3KB Share ATX Sustained Reduction in Tumour Size Seen In Pancreatic Trial 25/07/24 PRICE SENSITIVE download Created with Sketch. 170.67KB Share ATX First 26 Patients recruited in Phase 2A ACCENT Trial 03/07/24 PRICE SENSITIVE download Created with Sketch. 169.2KB Share ATX Preliminary Final Report and Annual Report YE 31 March 2024 30/05/24 PRICE SENSITIVE download Created with Sketch. 16.79MB Share ATX $4.27m Offer Successfully Completed and ACCENT Trial Update 15/05/24 PRICE SENSITIVE download Created with Sketch. 183.47KB Share ATX Quarterly Activities/Appendix 4C Cash Flow Report 30/04/24 PRICE SENSITIVE download Created with Sketch. 304.9KB Share ATX Rights Issue Investor Slide Deck 16/04/24 PRICE SENSITIVE download Created with Sketch. 5.96MB Share ATX Fully Underwritten 2 for 5 Entitlement Offer to raise $4.27 16/04/24 PRICE SENSITIVE download Created with Sketch. 167.5KB Share ATX Trading Halt 12/04/24 PRICE SENSITIVE download Created with Sketch. 209.46KB Share ATX Update on ACCENT Trial in Pancreatic Cancer 27/03/24 PRICE SENSITIVE download Created with Sketch. 169.3KB Share ATX Quarterly Activities/Appendix 4C Cash Flow Report 30/01/24 PRICE SENSITIVE download Created with Sketch. 393.35KB Share ATX FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US 18/01/24 PRICE SENSITIVE download Created with Sketch. 162.54KB Share ATX Trading Halt 17/01/24 PRICE SENSITIVE download Created with Sketch. 551.88KB Share ATX Pause in Trading 17/01/24 PRICE SENSITIVE download Created with Sketch. 114.79KB Share ATX Amplia Reports First Patient Dosing In Phase 2a Accent Trial 17/01/24 PRICE SENSITIVE download Created with Sketch. 169.03KB Share ATX Approval to Initiate Phase2 Pancreatic Cancer Trial in Korea 04/12/23 PRICE SENSITIVE download Created with Sketch. 166.59KB Share ATX Appendix 4D and Financial Report Half Year ended 30 Sep 23 21/11/23 PRICE SENSITIVE download Created with Sketch. 655.63KB Share ATX Quarterly Activities/Appendix 4C Cash Flow Report 31/10/23 PRICE SENSITIVE download Created with Sketch. 301.06KB Share ATX Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer 30/10/23 PRICE SENSITIVE download Created with Sketch. 179.92KB Share ATX Amplia Receives R&D Tax Rebate Totalling $ 2.4 Million 19/10/23 PRICE SENSITIVE download Created with Sketch. 109.36KB Share ATX AACR Ovarian Cancer Conference Presentation 09/10/23 PRICE SENSITIVE download Created with Sketch. 5.12MB Share ATX ATX Quarterly Activities and Cashflow Reports - June 23 Qtr 31/07/23 PRICE SENSITIVE download Created with Sketch. 307.66KB Share ATX Annual Report to Shareholders 30/05/23 PRICE SENSITIVE download Created with Sketch. 5.52MB Share ATX AMP945 and FOLFIRINOX active in model of Pancreatic Cancer 29/05/23 PRICE SENSITIVE download Created with Sketch. 197.6KB Share ATX Grant to collaborate with CSIRO Supplementary Announcement 23/05/23 PRICE SENSITIVE download Created with Sketch. 134.41KB Share ATX Amplia receives grant to collaborate with CSIRO 22/05/23 PRICE SENSITIVE download Created with Sketch. 130.74KB Share ATX ACCENT Trial Recruitment Progress 09/05/23 PRICE SENSITIVE download Created with Sketch. 161.79KB Share ATX Quarterly Activities and Cashflow Reports - March 23 Qtr 26/04/23 PRICE SENSITIVE download Created with Sketch. 275.01KB Share ATX First Patient Recruited to Cohort 3 of ACCENT Trial 19/04/23 PRICE SENSITIVE download Created with Sketch. 132.31KB Share ATX Dose Escalation Approved in ACCENT Clinical Trial of AMP945 11/04/23 PRICE SENSITIVE download Created with Sketch. 160.83KB Share ATX ACCENT Trial Recruitment Progress 28/02/23 PRICE SENSITIVE download Created with Sketch. 133.69KB Share ATX First Patient Recruited to Cohort 2 of Accent Trial 01/02/23 PRICE SENSITIVE download Created with Sketch. 131.5KB Share ATX Quarterly Activities and Cashflow Reports - December 2022 30/01/23 PRICE SENSITIVE download Created with Sketch. 340.02KB Share ATX Dose Escalation Approved in ACCENT Clinical Trial of AMP945 11/01/23 PRICE SENSITIVE download Created with Sketch. 165.61KB Share ATX Letter to Shareholders End of Year Summary and 2023 Plans 20/12/22 PRICE SENSITIVE download Created with Sketch. 3.21MB Share ATX ACCENT Trial Recruitment Progress 29/11/22 PRICE SENSITIVE download Created with Sketch. 103.3KB Share ATX Appendix 4D and Financial Report Half Year ended 30 Sep 22 18/11/22 PRICE SENSITIVE download Created with Sketch. 2.23MB Share ATX Amplia Appoints Dr Christopher Burns CEO & Managing Director 07/11/22 PRICE SENSITIVE download Created with Sketch. 132.58KB Share ATX Quarterly Activities and Cashflow Reports - Sep 2022 Qtr 28/10/22 PRICE SENSITIVE download Created with Sketch. 503.17KB Share ATX AMP886 Activity in Acute Myeloid Leukemia 03/10/22 PRICE SENSITIVE download Created with Sketch. 238.68KB Share ATX CEO Resignation 12/09/22 PRICE SENSITIVE download Created with Sketch. 103.1KB Share ATX Amplia Receives $1.8m R&D Tax Incentive 31/08/22 PRICE SENSITIVE download Created with Sketch. 104.17KB Share ATX CEO & Managing Director Presentation to AGM 25/08/22 PRICE SENSITIVE download Created with Sketch. 5.94MB Share ATX First Patient Recruited to ACCENT Trial in Pancreatic Cancer 02/08/22 PRICE SENSITIVE download Created with Sketch. 132.49KB Share ATX Quarterly Activities and Cashflow Reports - June 2022 Qtr 28/07/22 PRICE SENSITIVE download Created with Sketch. 371.69KB Share ATX AMP945 Shows Efficacy in Model of Lung Fibrosis 02/06/22 PRICE SENSITIVE download Created with Sketch. 182.84KB Share ATX Preliminary Final Report and Annual Report YE 31 March 2022 30/05/22 PRICE SENSITIVE download Created with Sketch. 2.92MB Share ATX Amplia Receives Second Ethics Clearance for Phase 2 Trial 13/05/22 PRICE SENSITIVE download Created with Sketch. 158.42KB Share ATX AMP945 Pre-IND Meeting Outcome 09/05/22 PRICE SENSITIVE download Created with Sketch. 133.54KB Share ATX Quarterly Activities and Cashflow Reports - March 2022 Qtr 19/04/22 PRICE SENSITIVE download Created with Sketch. 380.29KB Share ATX Ethics Clearance Phase 2 Trial - Pancreatic Cancer Patients 06/04/22 PRICE SENSITIVE download Created with Sketch. 187.1KB Share ATX AMP945 Improves Survival in Human Pancreatic Cancer Model 17/02/22 PRICE SENSITIVE download Created with Sketch. 232.86KB Share ATX Quarterly Activities and Cashflow Reports - Dec 2021 Qtr 24/01/22 PRICE SENSITIVE download Created with Sketch. 412.91KB Share ATX Amplia Completes Manufacture of AMP945 for Planned Trials 13/01/22 PRICE SENSITIVE download Created with Sketch. 133.41KB Share ATX Amplia Provides Updated Investor Presentation 16/12/21 PRICE SENSITIVE download Created with Sketch. 3.01MB Share ATX Entitlement Offer Completed 10/12/21 PRICE SENSITIVE download Created with Sketch. 105.92KB Share ATX Amplia Awarded $2.1M R&D Cash Flow Loan 02/12/21 PRICE SENSITIVE download Created with Sketch. 131.38KB Share ATX App 4D and Financial Report Half Year ended 30 Sep 2021 24/11/21 PRICE SENSITIVE download Created with Sketch. 868KB Share ATX Inhibition of FAK by AMP945 in Phase 1 Clinical Trial 17/11/21 PRICE SENSITIVE download Created with Sketch. 134.39KB Share ATX Capital Raising Investor Presentation 08/11/21 PRICE SENSITIVE download Created with Sketch. 2.08MB Share ATX Entitlement Offer Prospectus 08/11/21 PRICE SENSITIVE download Created with Sketch. 970.51KB Share ATX Placement and Underwritten Entitlement Offer to Raise $12.4m 08/11/21 PRICE SENSITIVE download Created with Sketch. 230.26KB Share ATX Trading Halt 04/11/21 PRICE SENSITIVE download Created with Sketch. 234.65KB Share ATX Quarterly Activities and Cashflow Reports - Sep 2021 Qtr 27/10/21 PRICE SENSITIVE download Created with Sketch. 346.77KB Share ATX Amplia Provides Updated Investor Presentation 19/10/21 PRICE SENSITIVE download Created with Sketch. 2.44MB Share ATX Amplia Receives $1.1m R&D Tax Incentive 14/10/21 PRICE SENSITIVE download Created with Sketch. 102.7KB Share ATX New Garvan Publication Supports Amplia Phase 2 Design 30/09/21 PRICE SENSITIVE download Created with Sketch. 158.96KB Share ATX Phase 2 Trial in First-Line Pancreatic Cancer Patients 15/09/21 PRICE SENSITIVE download Created with Sketch. 134.22KB Share ATX AGM - Chief Executive Officer's Presentatioin 27/08/21 PRICE SENSITIVE download Created with Sketch. 1.4MB Share ATX Quarterly Activities and Cashflow Reports and Presentation 28/07/21 PRICE SENSITIVE download Created with Sketch. 2.4MB Share ATX Results from Successful Phase 1 Clinical Trial of AMP945 21/07/21 PRICE SENSITIVE download Created with Sketch. 161.69KB Share ATX Amplia and Garvan Enter Into Collaboration Agreement 28/06/21 PRICE SENSITIVE download Created with Sketch. 110.05KB Share ATX AMP945 Improves Survival in Pacnreatic Cancer Model 02/06/21 PRICE SENSITIVE download Created with Sketch. 170.28KB Share ATX App 4E - Preliminary Final Report YE 31 March 2021 31/05/21 PRICE SENSITIVE download Created with Sketch. 327.33KB Share
(20min delay)
